COTA provides oncology research and development, regulatory, commercial, and HEOR teams with detailed real-world patient data to discover new treatment protocols and transform cancer care.
Real, longitudinal patient data across dozens of patient subgroups and oncology disease areas help pharmaceutical and biotech companies optimize their research, development, and commercialization strategies.
COTA data includes over 2M+ patients across a variety of cancer diagnoses, treatment settings, and demographics and is regularly maintained and updated to ensure quality, accuracy, relevance, and linkability.
Get access to a massive database of longitudinal real-world outcomes datasets curated to specific cancer types, subpopulations, or broad population research.
Get expert clinical insights, study design support, and statistical analysis.
Explore our collection of clinical research, recent press, podcasts, and more.
Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, has announced its partnership with COTA, an organization that brings clarity to cancer care with a precise, patient-first approach based on real-world…
Life science companies have many different data types at their disposal to support research and development, from established literature and clinical trial evidence to a growing range of real-world data (RWD) assets…
Internships are one of the most important tools for young people preparing to transition from academia to a full-time career. COTA has a long history of welcoming students from all different backgrounds…
Partner with COTA for the highest-quality curated cancer patient datasets.
